INHIBITION OF CANCER PROCOAGULANT BY PEPTIDYL DIAZOMETHYL KETONES AND PEPTIDYL SULFONIUM SALTS

被引：20

作者：

FALANGA, A

SHAW, E

DONATI, MB

CONSONNI, R

BARBUI, T

GORDON, S

机构：

[1] MARIO NEGRI INST,CONSORZIO NEGRI SUD,S MARIA IMBARO,ITALY

[2] OSPED RIUNITI BERGAMO,DIV HEMATOL,I-24100 BERGAMO,ITALY

[3] FRIEDRICH MIESCHER INST,CH-4002 BASEL,SWITZERLAND

[4] UNIV COLORADO,HLTH SCI CTR,DENVER,CO 80262

来源：

THROMBOSIS RESEARCH | 1989年 / 54卷 / 05期

关键词：

D O I：

10.1016/0049-3848(89)90209-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：389 / 398

页数：10

共 22 条

[1] PROTEOLYSIS, FIBRINOLYSIS, AND COAGULATION - SIGNIFICANCE IN THROMBOLYTIC THERAPY [J].

ALEXANDER, B ;

KLIMAN, A ;

PECHET, L .

CIRCULATION, 1962, 26 (04) :596-&

[2]

DONATI MB, 1986, CANCER RES, V46, P6471

[3]

FALANGA A, 1988, BLOOD, V71, P870

[4] ISOLATION AND CHARACTERIZATION OF CANCER PROCOAGULANT - A CYSTEINE PROTEINASE FROM MALIGNANT-TISSUE [J].

FALANGA, A ;

GORDON, SG .

BIOCHEMISTRY, 1985, 24 (20) :5558-5567

[5] COMPARISON OF PROPERTIES OF CANCER PROCOAGULANT AND HUMAN AMNION-CHORION PROCOAGULANT [J].

FALANGA, A ;

GORDON, SG .

BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 831 (01) :161-165

[6]

GORDON SG, 1985, BLOOD, V66, P1261

[7] A FACTOR X-ACTIVATING CYSTEINE PROTEASE FROM MALIGNANT-TISSUE [J].

GORDON, SG ;

CROSS, BA .

JOURNAL OF CLINICAL INVESTIGATION, 1981, 67 (06) :1665-1671

[8]

GORDON SG, 1978, CANCER RES, V38, P2467

[9]

GORDON SG, 1979, JNCI-J NATL CANCER I, V62, P773

[10]

GORDON SG, 1987, HEMOSTASIS CANCER, P19

← 1 2 3 →